348 related articles for article (PubMed ID: 33260160)
1. E3 ligase FBXW7 restricts M2-like tumor-associated macrophage polarization by targeting c-Myc.
Zhong L; Zhang Y; Li M; Song Y; Liu D; Yang X; Yang D; Qu H; Lai L; Wang Q; Chen Z
Aging (Albany NY); 2020 Dec; 12(23):24394-24423. PubMed ID: 33260160
[TBL] [Abstract][Full Text] [Related]
2. Guttiferone K impedes cell cycle re-entry of quiescent prostate cancer cells via stabilization of FBXW7 and subsequent c-MYC degradation.
Xi Z; Yao M; Li Y; Xie C; Holst J; Liu T; Cai S; Lao Y; Tan H; Xu HX; Dong Q
Cell Death Dis; 2016 Jun; 7(6):e2252. PubMed ID: 27253416
[TBL] [Abstract][Full Text] [Related]
3. The FBXW7-NOTCH interactome: A ubiquitin proteasomal system-induced crosstalk modulating oncogenic transformation in human tissues.
Kar R; Jha SK; Ojha S; Sharma A; Dholpuria S; Raju VSR; Prasher P; Chellappan DK; Gupta G; Kumar Singh S; Paudel KR; Hansbro PM; Kumar Singh S; Ruokolainen J; Kesari KK; Dua K; Jha NK
Cancer Rep (Hoboken); 2021 Aug; 4(4):e1369. PubMed ID: 33822486
[TBL] [Abstract][Full Text] [Related]
4. The anti-angiogenesis role of FBXW7 in diabetic retinopathy by facilitating the ubiquitination degradation of c-Myc to orchestrate the HDAC2.
Hu L; Lv X; Li D; Zhang W; Ran G; Li Q; Hu J
J Cell Mol Med; 2021 Feb; 25(4):2190-2202. PubMed ID: 33369138
[TBL] [Abstract][Full Text] [Related]
5. E3 ubiquitin ligase FBXW7 enhances radiosensitivity of non-small cell lung cancer cells by inhibiting SOX9 regulation of CDKN1A through ubiquitination.
Zhu H; Wang X; Zhou X; Lu S; Gu G; Liu C
Lab Invest; 2022 Nov; 102(11):1203-1213. PubMed ID: 35840806
[TBL] [Abstract][Full Text] [Related]
6. Loss of Fbxw7 synergizes with activated Akt signaling to promote c-Myc dependent cholangiocarcinogenesis.
Wang J; Wang H; Peters M; Ding N; Ribback S; Utpatel K; Cigliano A; Dombrowski F; Xu M; Chen X; Song X; Che L; Evert M; Cossu A; Gordan J; Zeng Y; Chen X; Calvisi DF
J Hepatol; 2019 Oct; 71(4):742-752. PubMed ID: 31195063
[TBL] [Abstract][Full Text] [Related]
7. Loss of FBXW7-mediated degradation of BRAF elicits resistance to BET inhibitors in adult T cell leukemia cells.
Yeh CH; Bellon M; Wang F; Zhang H; Fu L; Nicot C
Mol Cancer; 2020 Sep; 19(1):139. PubMed ID: 32907612
[TBL] [Abstract][Full Text] [Related]
8. Loss of Fbxw7 triggers mammary tumorigenesis associated with E2F/c-Myc activation and Trp53 mutation.
Meyer AE; Furumo Q; Stelloh C; Minella AC; Rao S
Neoplasia; 2020 Nov; 22(11):644-658. PubMed ID: 33070870
[TBL] [Abstract][Full Text] [Related]
9. FBXW7: a critical tumor suppressor of human cancers.
Yeh CH; Bellon M; Nicot C
Mol Cancer; 2018 Aug; 17(1):115. PubMed ID: 30086763
[TBL] [Abstract][Full Text] [Related]
10. Colorectal Cancer Stem Cells Acquire Chemoresistance Through the Upregulation of F-Box/WD Repeat-Containing Protein 7 and the Consequent Degradation of c-Myc.
Izumi D; Ishimoto T; Miyake K; Eto T; Arima K; Kiyozumi Y; Uchihara T; Kurashige J; Iwatsuki M; Baba Y; Sakamoto Y; Miyamoto Y; Yoshida N; Watanabe M; Goel A; Tan P; Baba H
Stem Cells; 2017 Sep; 35(9):2027-2036. PubMed ID: 28699179
[TBL] [Abstract][Full Text] [Related]
11. E3 ligase FBXW7 is critical for RIG-I stabilization during antiviral responses.
Song Y; Lai L; Chong Z; He J; Zhang Y; Xue Y; Xie Y; Chen S; Dong P; Chen L; Chen Z; Dai F; Wan X; Xiao P; Cao X; Liu Y; Wang Q
Nat Commun; 2017 Mar; 8():14654. PubMed ID: 28287082
[TBL] [Abstract][Full Text] [Related]
12. RANBP10 promotes glioblastoma progression by regulating the FBXW7/c-Myc pathway.
Hou J; Liu Y; Huang P; Wang Y; Pei D; Tan R; Zhang Y; Cui H
Cell Death Dis; 2021 Oct; 12(11):967. PubMed ID: 34671019
[TBL] [Abstract][Full Text] [Related]
13. E3 ligase FBXW7 aggravates TMPD-induced systemic lupus erythematosus by promoting cell apoptosis.
Chong Z; Bao C; He J; Chen T; Zhong L; Li G; Li H; Fang L; Song Y; Fu G; Yang X; Lai L; Liu Y; Wang Q
Cell Mol Immunol; 2018 Dec; 15(12):1057-1070. PubMed ID: 30275535
[TBL] [Abstract][Full Text] [Related]
14. Rictor regulates FBXW7-dependent c-Myc and cyclin E degradation in colorectal cancer cells.
Guo Z; Zhou Y; Evers BM; Wang Q
Biochem Biophys Res Commun; 2012 Feb; 418(2):426-32. PubMed ID: 22285861
[TBL] [Abstract][Full Text] [Related]
15. Role of FBXW7 in the quiescence of gefitinib-resistant lung cancer stem cells in EGFR-mutant non-small cell lung cancer.
Hidayat M; Mitsuishi Y; Takahashi F; Tajima K; Yae T; Miyahara K; Hayakawa D; Winardi W; Ihara H; Koinuma Y; Wirawan A; Nurwidya F; Kato M; Kobayashi I; Sasaki S; Takamochi K; Hayashi T; Suehara Y; Moriyama M; Moriyama H; Habu S; Takahashi K
Bosn J Basic Med Sci; 2019 Nov; 19(4):355-367. PubMed ID: 31202256
[TBL] [Abstract][Full Text] [Related]
16. Recent insight into the role of FBXW7 as a tumor suppressor.
Yumimoto K; Nakayama KI
Semin Cancer Biol; 2020 Dec; 67(Pt 2):1-15. PubMed ID: 32113998
[TBL] [Abstract][Full Text] [Related]
17. Aberrant FBXW7-mediated ubiquitination and degradation of ZMYND8 enhances tumor progression and stemness in bladder cancer.
Qiu F; Jin Y; Pu J; Huang Y; Hou J; Zhao X; Lu Y
Exp Cell Res; 2021 Oct; 407(2):112807. PubMed ID: 34487730
[TBL] [Abstract][Full Text] [Related]
18. CDK1/FBXW7 facilitates degradation and ubiquitination of MLST8 to inhibit progression of renal cell carcinoma.
Zhang E; Chen S; Tang H; Fei C; Yuan Z; Mu X; Qin Y; Liu H; Fan Y; Tan M; Wang X
Cancer Sci; 2022 Jan; 113(1):91-108. PubMed ID: 34741373
[TBL] [Abstract][Full Text] [Related]
19. Lysine-52 stabilizes the MYC oncoprotein through an SCF
De Melo J; Kim SS; Lourenco C; Penn LZ
Oncogene; 2017 Dec; 36(49):6815-6822. PubMed ID: 28806398
[TBL] [Abstract][Full Text] [Related]
20. MYC is a critical target of FBXW7.
Sato M; Rodriguez-Barrueco R; Yu J; Do C; Silva JM; Gautier J
Oncotarget; 2015 Feb; 6(5):3292-305. PubMed ID: 25669969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]